DISCOUNT OPTIONSSCHEIN - AMGEN | Delayed Börse Stuttgart 03:34:28 2024-05-13 EDT | ||
| 4.09 EUR | -0.49% |
|
| Current month | +92.06% | ||
| 1 month | +83.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 4.09 | -0.49% | 0 |
| 24-05-10 | 4.11 | -4.86% | 0 |
| 24-05-09 | 4.32 | +17.07% | 0 |
| 24-05-08 | 3.69 | +10.81% | 0 |
| 24-05-07 | 3.33 | -22.38% | 0 |
Delayed Quote Börse Stuttgart
Last update May 13, 2024 at 03:34 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME6QK2 |
| ISIN | DE000ME6QK20 |
| Date issued | 2024-01-10 |
| Strike | 380 $ |
| Maturity | 2024-12-20 (221 Days) |
| Parity | 1 : 1 |
| Emission price | 3.35 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.36 € |
|---|---|
| Lowest since issue | 1.77 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat